We utilize Artificial Neural Networks to develop novel geroprotectors (small molecules that are able to slow down aging). We then test the proposed molecules in the short-living nematode worm C. elegans for the ability to prolong the lifespan. Successful candidates (with pro-longevity effect) later go into trial in elderly rats to understand the mechanism of action and the ability to prolong life in mammals. As aging is (yet) not considered a disease - we plan to patent our small molecules as drugs against age-associated disease based on their target/mechanism of action.